Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Berberine for Hyperlipidemia in Chinese Women
NCT06782646Phase 3Enrolling by invitation
- Sponsor
- The University of Hong Kong
- Start
- Aug 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of berberine in hyperlipidemia, sponsored by The University of Hong Kong. Started Aug 2024; status: enrolling by invitation.
02
Drugs
berberine
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NCT06782646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06782646.